Vertex Pharmaceuticals
Company Details
Linkedin ID:
vertex-pharmaceuticals
Website:
Employees number:
6,124
Number of followers:
530,902
NAICS:
541714
Industry Type:
Homepage:
vrtx.com
IP Addresses:
81
Company ID:
VER_2771813
Scan Status:
Completed
Vertex Pharmaceuticals Company CyberSecurity Posture
vrtx.com
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and have made significant advancements in multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continue to progress clinical and research programs in these diseases. We also have a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where we have deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency. Our global HQ is in Boston, and we have research and development (R&D) sites and commercial offices worldwide. Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. We have also earned a spot on TIME Most Influential Companies, TIME Best Inventions, and Fast Company Most Innovative Companies lists. Our research and medicines have received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the Prix Galien, the Scrip Award and the Breakthrough Prize awards. Read our community guidelines: https://www.vrtx.com/vertexs-community-guidelines/
Vertex Pharmaceuticals A.I CyberSecurity Scoring
Vertex Pharmaceuticals Risk Score (AI oriented)Between 750 and 799
Vertex Pharmaceuticals
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
Vertex Pharmaceuticals Global Score (TPRM)XXXX
Vertex Pharmaceuticals
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
Vertex Pharmaceuticals Company CyberSecurity News & History
Past Incidents
0
Attack Types
0
No data available
Vertex Pharmaceuticals Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for Vertex Pharmaceuticals
Incidents vs Biotechnology Research Industry Average (This Year)
No incidents recorded for Vertex Pharmaceuticals in 2025.
Incidents vs All-Companies Average (This Year)
No incidents recorded for Vertex Pharmaceuticals in 2025.
Incident Types Vertex Pharmaceuticals vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Vertex Pharmaceuticals in 2025.
Incident History — Vertex Pharmaceuticals (X = Date, Y = Severity)
Vertex Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries
Vertex Pharmaceuticals Company Subsidiaries
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and have made significant advancements in multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continue to progress clinical and research programs in these diseases. We also have a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where we have deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency. Our global HQ is in Boston, and we have research and development (R&D) sites and commercial offices worldwide. Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. We have also earned a spot on TIME Most Influential Companies, TIME Best Inventions, and Fast Company Most Innovative Companies lists. Our research and medicines have received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the Prix Galien, the Scrip Award and the Breakthrough Prize awards. Read our community guidelines: https://www.vrtx.com/vertexs-community-guidelines/
Loading...
Vertex Pharmaceuticals Similar Companies
Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to eva
At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all
About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research,
CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by ou
Biocon
Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a vision to enhance global heal
bioMérieux
A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in v
The National Institutes of Health
NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness an
About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions s
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals w
.png)
Vertex Pharmaceuticals CyberSecurity News
November 14, 2025 06:47 PM
About Us - Great American Insurance Group - Specialty Property & Casualty Insurance
The global financial markets are in the midst of a profound transformation, driven by an accelerating wave of technological advancements.
October 25, 2025 07:00 AM
Vertex Pharmaceuticals Stock Forecast: Where Analysts See the Stock Going by 2027
Here's why analysts believe Vertex Pharmaceuticals (NASDAQ: VRTX) stock could see about 22% upside by 2027, driven by strong margins,...
March 21, 2025 07:00 AM
Why CFOs and CIOs are in a power struggle over AI
Good morning. CFOs and chief information officers (CIOs) steer technology to meet business needs. That also means justifying large AI...
February 21, 2025 08:00 AM
Cyril Amarchand Mangaldas guides Vertex Ventures in $16 Million Series A funding for AI platform Spyne
Cybersecurity: Vertex Ventures, with Cyril Amarchand Mangaldas as their legal advisor, led a Series A funding round, raising USD 16 million...
December 21, 2024 08:00 AM
My Top 10 Stocks to Buy for 2025
Here are my top 10 buys -- in no particular order -- for 2025 and beyond. Most of these stocks have a solid earnings track record.
September 05, 2024 07:00 AM
Five reasons to dive into our Tech Trends Outlook
Our newest Technology Trends Outlook offers a pragmatic, holistic, and highly readable view of the technologies that are shaping our lives.
July 31, 2024 07:00 AM
FDA accepts NDA for Vertex’s non-opioid pain drug
Vertex Pharmaceuticals revealed that the FDA has accepted its NDA for suzetrigine, a non-opioid pain inhibitor.
May 20, 2024 07:00 AM
Fenwick Represents Alpine Immune Sciences in its Acquisition by…
Vertex acquired all the outstanding shares of Alpine for $65 per share, for an aggregate value of approximately $4.9 billion.
November 28, 2023 08:00 AM
Article | What to know about looming FDA decision on first gene-editing therapy
The FDA will soon decide whether to approve a first-in-class, one-time gene-editing treatment to potentially cure a rare genetic blood...
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
Vertex Pharmaceuticals CyberSecurity History Information
Official Website of Vertex Pharmaceuticals
The official website of Vertex Pharmaceuticals is https://www.vrtx.com/.
Vertex Pharmaceuticals’s AI-Generated Cybersecurity Score
According to Rankiteo, Vertex Pharmaceuticals’s AI-generated cybersecurity score is 763, reflecting their Fair security posture.
How many security badges does Vertex Pharmaceuticals’ have ?
According to Rankiteo, Vertex Pharmaceuticals currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Does Vertex Pharmaceuticals have SOC 2 Type 1 certification ?
According to Rankiteo, Vertex Pharmaceuticals is not certified under SOC 2 Type 1.
Does Vertex Pharmaceuticals have SOC 2 Type 2 certification ?
According to Rankiteo, Vertex Pharmaceuticals does not hold a SOC 2 Type 2 certification.
Does Vertex Pharmaceuticals comply with GDPR ?
According to Rankiteo, Vertex Pharmaceuticals is not listed as GDPR compliant.
Does Vertex Pharmaceuticals have PCI DSS certification ?
According to Rankiteo, Vertex Pharmaceuticals does not currently maintain PCI DSS compliance.
Does Vertex Pharmaceuticals comply with HIPAA ?
According to Rankiteo, Vertex Pharmaceuticals is not compliant with HIPAA regulations.
Does Vertex Pharmaceuticals have ISO 27001 certification ?
According to Rankiteo,Vertex Pharmaceuticals is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of Vertex Pharmaceuticals
Vertex Pharmaceuticals operates primarily in the Biotechnology Research industry.
Number of Employees at Vertex Pharmaceuticals
Vertex Pharmaceuticals employs approximately 6,124 people worldwide.
Subsidiaries Owned by Vertex Pharmaceuticals
Vertex Pharmaceuticals presently has no subsidiaries across any sectors.
Vertex Pharmaceuticals’s LinkedIn Followers
Vertex Pharmaceuticals’s official LinkedIn profile has approximately 530,902 followers.
NAICS Classification of Vertex Pharmaceuticals
Vertex Pharmaceuticals is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).
Vertex Pharmaceuticals’s Presence on Crunchbase
No, Vertex Pharmaceuticals does not have a profile on Crunchbase.
Vertex Pharmaceuticals’s Presence on LinkedIn
Yes, Vertex Pharmaceuticals maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/vertex-pharmaceuticals.
Cybersecurity Incidents Involving Vertex Pharmaceuticals
As of November 27, 2025, Rankiteo reports that Vertex Pharmaceuticals has not experienced any cybersecurity incidents.
Number of Peer and Competitor Companies
Vertex Pharmaceuticals has an estimated 4,337 peer or competitor companies worldwide.
Vertex Pharmaceuticals CyberSecurity History Information
How many cyber incidents has Vertex Pharmaceuticals faced ?
Total Incidents: According to Rankiteo, Vertex Pharmaceuticals has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at Vertex Pharmaceuticals ?
Incident Types: The types of cybersecurity incidents that have occurred include .
Incident Details
What are the most common types of attacks the company has faced ?
Additional Questions
.png)
Latest Global CVEs (Not Company-Specific)
Description
Angular is a development platform for building mobile and desktop web applications using TypeScript/JavaScript and other languages. Prior to versions 19.2.16, 20.3.14, and 21.0.1, there is a XSRF token leakage via protocol-relative URLs in angular HTTP clients. The vulnerability is a Credential Leak by App Logic that leads to the unauthorized disclosure of the Cross-Site Request Forgery (XSRF) token to an attacker-controlled domain. Angular's HttpClient has a built-in XSRF protection mechanism that works by checking if a request URL starts with a protocol (http:// or https://) to determine if it is cross-origin. If the URL starts with protocol-relative URL (//), it is incorrectly treated as a same-origin request, and the XSRF token is automatically added to the X-XSRF-TOKEN header. This issue has been patched in versions 19.2.16, 20.3.14, and 21.0.1. A workaround for this issue involves avoiding using protocol-relative URLs (URLs starting with //) in HttpClient requests. All backend communication URLs should be hardcoded as relative paths (starting with a single /) or fully qualified, trusted absolute URLs.
Risk Information
cvss4
Base: 7.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
- https://github.com/angular/angular/commit/0276479e7d0e280e0f8d26fa567d3b7aa97a516f
- https://github.com/angular/angular/commit/05fe6686a97fa0bcd3cf157805b3612033f975bc
- https://github.com/angular/angular/commit/3240d856d942727372a705252f7c8c115394a41e
- https://github.com/angular/angular/releases/tag/19.2.16
- https://github.com/angular/angular/releases/tag/20.3.14
- https://github.com/angular/angular/releases/tag/21.0.1
- https://github.com/angular/angular/security/advisories/GHSA-58c5-g7wp-6w37
Description
Forge (also called `node-forge`) is a native implementation of Transport Layer Security in JavaScript. An Uncontrolled Recursion vulnerability in node-forge versions 1.3.1 and below enables remote, unauthenticated attackers to craft deep ASN.1 structures that trigger unbounded recursive parsing. This leads to a Denial-of-Service (DoS) via stack exhaustion when parsing untrusted DER inputs. This issue has been patched in version 1.3.2.
Risk Information
cvss4
Base: 8.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
Forge (also called `node-forge`) is a native implementation of Transport Layer Security in JavaScript. An Integer Overflow vulnerability in node-forge versions 1.3.1 and below enables remote, unauthenticated attackers to craft ASN.1 structures containing OIDs with oversized arcs. These arcs may be decoded as smaller, trusted OIDs due to 32-bit bitwise truncation, enabling the bypass of downstream OID-based security decisions. This issue has been patched in version 1.3.2.
Risk Information
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
Suricata is a network IDS, IPS and NSM engine developed by the OISF (Open Information Security Foundation) and the Suricata community. Prior to versions 7.0.13 and 8.0.2, working with large buffers in Lua scripts can lead to a stack overflow. Users of Lua rules and output scripts may be affected when working with large buffers. This includes a rule passing a large buffer to a Lua script. This issue has been patched in versions 7.0.13 and 8.0.2. A workaround for this issue involves disabling Lua rules and output scripts, or making sure limits, such as stream.depth.reassembly and HTTP response body limits (response-body-limit), are set to less than half the stack size.
Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Description
Suricata is a network IDS, IPS and NSM engine developed by the OISF (Open Information Security Foundation) and the Suricata community. In versions from 8.0.0 to before 8.0.2, a NULL dereference can occur when the entropy keyword is used in conjunction with base64_data. This issue has been patched in version 8.0.2. A workaround involves disabling rules that use entropy in conjunction with base64_data.
Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=vertex-pharmaceuticals' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
